Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Calliditas Therapeutics AB

Closing information (x1000 SEK)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 802,879 Less Arrow 229,347 Less Arrow 874
Financial expenses 37,669 Less Arrow 9,253 More Arrow 56,978
Earnings before taxes -409,417 Less Arrow -513,373 More Arrow -436,151
EBITDA -409,030 Less Arrow -524,456 More Arrow -376,897
Total assets 1,952,973 Less Arrow 1,459,910 More Arrow 1,506,450
Current assets 1,412,204 Less Arrow 1,012,772 More Arrow 1,036,851
Current liabilities 325,230 Less Arrow 135,446 Less Arrow 105,619
Equity capital 766,263 More Arrow 1,008,281 More Arrow 1,210,491
- share capital 2,383 Less Arrow 2,094 Less Arrow 1,998
Employees (average) 86 Less Arrow 56 Less Arrow 23

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 39.2% More Arrow 69.1% More Arrow 80.4%
Turnover per employee 9,336 Less Arrow 4,095 Less Arrow 38
Profit as a percentage of turnover -51.0% Less Arrow -223.8% Less Arrow -49902.9%
Return on assets (ROA) -19.0% Less Arrow -34.5% More Arrow -25.2%
Current ratio 434.2% More Arrow 747.7% More Arrow 981.7%
Return on equity (ROE) -53.4% More Arrow -50.9% More Arrow -36.0%
Change turnover 573,532 Less Arrow 228,473 Less Arrow -183,955
Change turnover % 250% More Arrow 26141% Less Arrow -100%
Chg. No. of employees 30 More Arrow 33 Less Arrow 9
Chg. No. of employees % 54% More Arrow 143% Less Arrow 64%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.